Caricamento...
Predictive biomarkers of response to immune checkpoint inhibitors in melanoma
INTRODUCTION: Advanced melanoma has recently been transformed by the advent of immune checkpoint inhibitors. These agents have altered the prognosis of this disease from a median survival of <1 year to recent data showing a 5-year survival surpassing 50%. Combination regimens combining PD-1 and C...
Salvato in:
| Pubblicato in: | Expert Rev Anticancer Ther |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7040956/ https://ncbi.nlm.nih.gov/pubmed/31997676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737140.2020.1724539 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|